Generation and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3

Yuya Araki1, Tatemitsu Rai2, Eisei Sohara1

  • 1Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-0034, Japan.

Biology Open
|October 23, 2015
PubMed

Insights

Pseudohypoaldosteronism type II (PHAII) is a rare genetic hypertension. Cul3 mutations causing PHAII do not lead to exon skipping in kidneys, suggesting other mechanisms are involved in this kidney-specific disease.

Area of Science:

  • Nephrology
  • Genetics
  • Molecular Biology

Background:

  • Pseudohypoaldosteronism type II (PHAII) is an inherited hypertension linked to mutations in WNK, KLHL3, and Cul3 genes.
  • The Cul3-KLHL3 E3 ligase complex normally ubiquitinates WNK4, reducing its expression; PHAII mutations disrupt this process.
  • The specific role of Cul3 mutations in PHAII pathogenesis, particularly in the kidneys, remains unclear.

Purpose of the Study:

  • To investigate the in vivo molecular mechanisms of PHAII caused by Cul3 mutations in the kidney.
  • To determine if Cul3 mutations lead to exon skipping in the kidney and contribute to PHAII phenotypes.

Main Methods:

  • Generated knock-in mice with a PHAII-associated Cul3 mutation (c.1207-1G>A).
  • Analyzed Cul3 mRNA levels and exon 9 skipping in the kidneys of heterozygous and homozygous knock-in mice.
  • Assessed PHAII phenotypes in heterozygous knock-in mice.

Main Results:

  • Heterozygous Cul3(G(-1)A/+) mice did not display PHAII phenotypes or exon 9 skipping in kidneys.
  • Cul3 mRNA levels were halved in heterozygous knock-in mouse kidneys.
  • Homozygous knock-in mice were nonviable, indicating the mutant allele acts like a knockout.

Conclusions:

  • Cul3 mutations causing PHAII do not induce exon 9 skipping in mouse kidneys.
  • Reduced Cul3 expression alone is insufficient to cause PHAII.
  • The pathogenic role of mutant Cul3 protein, rather than exon skipping, likely underlies kidney-predominant PHAII phenotypes.